Taurine 7 pp 293-303 | Cite as

The Protective Effect of Taurine Against Hepatic Damage in a Model of Liver Disease and Hepatic Stellate Cells

  • Teruo Miyazaki
  • Bernard Bouscarel
  • Tadashi Ikegami
  • Akira Honda
  • Yasushi Matsuzaki
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 643)

Abstract

Taurine plays a protective role against free radicals and toxins in various cells and tissues. However, the effect of taurine on hepatic injury and fibrosis developed by activated hepatic stellate cells (HSC) and myofibroblast-like cells is not fully understood. We investigated the effects of taurine on the hepatic fibrogenesis and damage in rats and isolated HSC. Rats were divided into a normal and two CCl4-induced liver damage (LD) groups, one untreated and the other maintained for 5 weeks on a 2% taurine diet. The HSC isolated from a normal rat were cultured either for a day only or for an additional 3–6 days with ~50 mM taurine. LD rats maintained on the taurine diet were resistant to CCl4-induced loss of taurine from the liver. The liver of the LD rats were also protected against histological damage, fibrosis, significant reductions in oxidative stress markers (LPO and 8-OHdG) and hepatic fibrogenic factors (TGF-β1 mRNA, hydroxyproline, α-SMA). Proliferation, oxidative stress, and fibrogenesis were significantly inhibited in HSC by treatment with taurine. Thus, supplementation with taurine should be considered as a therapeutic approach to lessen the severity of oxidative stress-induced liver injury and hepatic fibrosis.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Awapara J (1956) The taurine concentration of organs from fed and fasted rats. J Biol Chem 218(2):571-6.PubMedGoogle Scholar
  2. Azuma J, Hamaguchi T, Ohta H, Takihara K, Awata N, Sawamura A, Harada H, Tanaka Y, Kishimoto S (1987) Calcium overload-induced myocardial damage caused by isoproterenol and by adriamycin: possible role of taurine in its prevention. Adv Exp Med Biol 217:167–179PubMedGoogle Scholar
  3. Balkan J, Dogru-Abbasoglu S, Kanbagli O, Cevikbas U, Aykac-Toker G, Uysal M (2001) Taurine has a protective effect against thioacetamide-induced liver cirrhosis by decreasing oxidative stress. Hum Exp Toxicol 20:251–254PubMedCrossRefGoogle Scholar
  4. Danielsson H (1963) Present status of research on catabolism, excretion of cholesterol. Adv Lipid Res 1:335–385PubMedGoogle Scholar
  5. Davison AN, Kaczmarec LK (1971) Taurine-a possible neurotransmitter? Nature 234:107–108PubMedCrossRefGoogle Scholar
  6. Dinçcer S, Özenirler S, Öz E, Akyol G, Özogul C (2002) The protective effect of taurine pretreatment on carbon tetrachloride-induced hepatic damage – A light and electron microscopic study. Amino Acids 22:417–426CrossRefGoogle Scholar
  7. Enzan H, Himeno H, Iwamura S, Saibara T, Onishi S, Yamamoto Y, Hara H (1994) Immunohistochemical identification of Ito cells and their myofibroblastic transformation in adult human liver. Virchows Arch 424:249–256PubMedCrossRefGoogle Scholar
  8. Friedman SL (1993) Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 328:1828–1835PubMedCrossRefGoogle Scholar
  9. Fukuda K, Hirai Y, Yoshida H, Nakajima T, Usui T (1982) Free amino acid content of lymphocytes and granulocytes compared. Clin Chem 28:1758–1761PubMedGoogle Scholar
  10. Gordon RE, Heller RF, Heller RF (1992) Taurine protection of lungs in hamster models of oxidant injury: a morphologic time study of paraquat and bleomycin treatment. Adv Exp Med Biol 315:319–328PubMedGoogle Scholar
  11. Green TR, Fellman JH, Eicher AL, Pratt KL (1991) Antioxidant role and subcellular location of hypotaurine and taurine in human neutrophils. Biochim Biophys Acta 1073:91–97PubMedGoogle Scholar
  12. Gressner AM (1996) Transdifferentiation of hepatic stellate cells (Ito cells) to myofibroblasts: a key event in hepatic fibrogenesis. Kidney Int Suppl 54:S39–S45PubMedGoogle Scholar
  13. Hosokawa Y, Matsumoto A, Oka J, Itakura H, Yamaguchi K (1990) Isolation and characterization of a cDNA for rat liver cysteine dioxygenase. Biochem Biophys Res Commun 168:473–478PubMedCrossRefGoogle Scholar
  14. Huxtable RJ (1980) Does taurine have a function? Fed Proc 39:2678–2679PubMedGoogle Scholar
  15. Huxtable RJ (1992) Physiological actions of taurine. Physiol Rev 72:101–163PubMedGoogle Scholar
  16. Jacobsen JG, Swimth LH (1968) Biochemistry and physiology of taurine and taurine derivatives. Physiol Rev 48:424–511PubMedGoogle Scholar
  17. Kaisaki PJ, Jerkins AA, Goodspeed DC, Steele RD (1995) Cloning and characterization of rat cysteine sulfinic acid decarboxylase. Biochim Biophys Acta 1262:79–82PubMedGoogle Scholar
  18. Kanner BI, Nurit KD (1994) Structure and function of sodium-coupled neurotransmitter transporters. Cell Physiol Biochem 4:174CrossRefGoogle Scholar
  19. Koyama I, Nakamura T, Ogasawara M, Nemoto M, Yoshida T (1992) The protective effect of taurine on the biomembrane against damage produced by the oxygen radical. Adv Exp Med Biol 315:355–359PubMedGoogle Scholar
  20. Kuriyama K (1980) Taurine as a neuromodulator. Fed Proc 39:2680–2684PubMedGoogle Scholar
  21. Li D, Friedman SL (1999) Liver fibrogenesis and the role of hepatic stellate cells: new insights and prospects for therapy. J Gastroenterol Hepatol 14:618–633PubMedCrossRefGoogle Scholar
  22. Ludwig J (1993) The nomenclature of chronic active hepatitis:an obituary. Gastroenterol 105: 274–278Google Scholar
  23. Matsuzaki Y, Miyazaki T, Miyakawa S, Bouscarel B, Ikegami T, Tanaka N (2002a) Decreased taurine concentration in skeletal muscles after exercise for various durations. Med Sci Sports Exerc 34:793–797CrossRefGoogle Scholar
  24. Matsuzaki Y, Miyazaki T, Ohkoshi N, Miyakawa S, Bouscarel B, Tanaka N (2002b) Degeneration of skeletal muscle fibers in the rat administrated carbon tetrachloride:similar histological findings of the muscle in a 64-year-old patient of LC with muscle cramp. Hepatol Res 24:368–378CrossRefGoogle Scholar
  25. Mihaljevic B, Katusin-Razem B, Razem D (1996) The reevaluation of the ferric thiocyanate assay for lipid hydroperoxides with special considerations of the mechanistic aspects of the response. Free Radic Biol Med 21:53–63PubMedCrossRefGoogle Scholar
  26. Miyazaki T, Ikegami T, Zhang Y, Honda A, Doy M, Matsuzaki Y (2005) The prevention mechanisms of taurine on hepatic damage and fibrosis via antioxidative stress. Jpn Pharmacol Ther 33:S105Google Scholar
  27. Miyazaki T, Matsuzaki Y, Ikegami T, Miyakawa S, Doy M, Tanaka N, Bouscarel B (2004a) Optimal and effective oral dose of taurine to prolong exercise performance in rat. Amino Acids 27:291–298CrossRefGoogle Scholar
  28. Miyazaki T, Matsuzaki Y, Ikegami T, Miyakawa S, Doy M, Tanaka N, Bouscarel B (2004b) The harmful effect of exercise on reducing taurine concentration in the tissues of rats treated with CCl4 administration. J Gastroenterol 39:557–562Google Scholar
  29. Miyazaki T, Matsuzaki Y, Karube M, Bouscarel B, Miyakawa S, Tanaka N (2003a) Amino acid ratios in plasma and tissues in a rat model of liver cirrhosis before and after exercise. Hepatol Res 27:230–237CrossRefGoogle Scholar
  30. Miyazaki T, Matsuzaki Y, Karube M, Miyakawa S, Tanaka N (2003b) Clinical importance of taurine maintenance on liver disease. Gastroenterology 37:558–562Google Scholar
  31. Nakashima T, Seto Y, Nakajima T, Shima T, Sakamoto Y, Cho N, Sano A, Iwai M, Kagawa K, Okanoue T, et al. (1990) Calcium-associated cytoprotective effect of taurine on the calcium and oxygen paradoxes in isolated rat hepatocytes. Liver 10:167–172PubMedGoogle Scholar
  32. Nakatsukasa H, Nagy P, Evarts RP, Hsia CC, Marsden E, Thorgeirsson SS (1990) Cellular distribution of transforming growth factor-beta 1 and procollagen types I, III, and IV transcripts in carbon tetrachloride- induced rat liver fibrosis. J Clin Invest 85:1833–1843PubMedCrossRefGoogle Scholar
  33. Nieminen ML, Tuomisto L, Solatunturi E, Eriksson L, Paasonen MK (1988) Taurine in the osmoregulation of the Brattleboro rat. Life Sci 42:2137–2143PubMedCrossRefGoogle Scholar
  34. Pasantes MH, Wright CE, Gaull GE (1984) Protective effect of taurine, zinc and tocopherol on retinol-induced damage in human lymphoblastoid cells. J Nutr 114:2256–2261Google Scholar
  35. Pasantes MH, Wright CE, Gaull GE (1985) Taurine protection of lymphoblastoid cells from iron-ascorbate induced damage. Biochem Pharmacol 34:2205–2207CrossRefGoogle Scholar
  36. Reymond I, Sergeant A, Tappaz M (1996) Molecular cloning and sequence analysis of the cDNA encoding rat liver cysteine sulfinate decarboxylase (CSD). Biochim Biophys Acta 1307: 152–156PubMedGoogle Scholar
  37. Schafer S, Zerbe O, Gressner AM (1987) The synthesis of proteoglycans in fat-storing cells of rat liver. Hepatology 7:680–687PubMedCrossRefGoogle Scholar
  38. Sjovall J (1959) Dietary glycine and taurine on bile acid conjugation in man; bile acids and steroids 75. Proc Soc Exp Biol Med 100:676–678PubMedGoogle Scholar
  39. Sturman JA (1993) Taurine in development. Physiol Rev 73:119–147PubMedGoogle Scholar
  40. Tappaz M, Bitoun M, Reymond I, Sergeant A (1999) Characterization of the cDNA coding for rat brain cysteine sulfinate decarboxylase: brain and liver enzymes are identical proteins encoded by two distinct mRNAs. J Neurochem 73:903–912PubMedCrossRefGoogle Scholar
  41. Timbrell JA, Seabra V, Waterfield CJ (1995) The in vivo and in vitro protective properties of taurine. Gen Pharmacol 26:453–462PubMedGoogle Scholar
  42. Vohra BP, Hui X (2001) Taurine protects against carbon tetrachloride toxicity in the cultured neurons and in vivo. Arch Physiol Biochem 109:90–94PubMedCrossRefGoogle Scholar
  43. Wang QJ, Giri SN, Hyde DM, Li C (1991) Amelioration of bleomycin-induced pulmonary fibrosis in hamsters by combined treatment with taurine and niacin. Biochem Pharmacol 42:1115–1122PubMedCrossRefGoogle Scholar
  44. Waterfield C.J, Mesquita M, Parnham P, Timbrell J.A (1993a) Taurine protects against the cytotoxicity of hydrazine, 1,4-naphthoquinone and carbon tetrachloride in isolated rat hepatocytes. Biochem Pharmacol 46:589–595CrossRefGoogle Scholar
  45. Waterfield CJ, Turton JA, Scales MD, Timbrell JA (1993b) Reduction of liver taurine in rats by beta-alanine treatment increases carbon tetrachloride toxicity. Toxicology 29:7–20CrossRefGoogle Scholar
  46. Wright CE, Lin TT, Lin YY, Sturman JA, Gaull GE (1985) Taurine scavenges oxidized chlorine in biological systems. Prog Clin Biol Res 179:137–147PubMedGoogle Scholar
  47. Zhang Y, Ikegami T, Honda A, Miyazaki T, Bouscarel B, Rojkind M, Hyodo I, Matsuzaki Y (2006) Involvement of integrin-linked kinase in carbon tetrachloride-induced hepatic fibrosis in rats. Hepatology 44:612–622PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Teruo Miyazaki
    • 1
  • Bernard Bouscarel
  • Tadashi Ikegami
  • Akira Honda
  • Yasushi Matsuzaki
  1. 1.The George Washington UniversityDistrict of ColumbiaUSA

Personalised recommendations